SPOTLIGHT -
Take a look at what happenend in the Glaucoma field in 2007.
Federal investment and regulatory benefits draw biotech firms to Switzerland
The country is home to 20% of biotechs headquartered in Europe.
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
Upgrading cataract surgery skills – Unlocking the full potential of surgical video review using an AI-based application
Updates From Angiogenesis-2022
Preservative-free latanoprost as effective as BAK-preserved latanoprost
Therapeutic has fewer adverse effects in patients with POAG and OHT, study results show
The complicated ins and outs of paediatric glaucoma
Early detection and diagnosis are key for these young patients.
